Form D · Biotechnology
TENGION INC
Winston Salem, NC · CIK 0001296391
Offering snapshot reported Aug 7, 2013 · SEC filing
- Reported sold
- $74.3M Offering amount: $74.3M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2013 | Initial | $74,304,002 | No comparison | 22 | SEC filing |
| Oct 10, 2012 | Initial | $15,005,251 | No comparison | 15 | SEC filing |
| Sep 21, 2012 | Initial | $1,000,000 | No comparison | 9 | SEC filing |
| Mar 16, 2011 | Initial | $31,354,278 | No comparison | 43 | SEC filing |
| Nov 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 21, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.02M
- Finders' fees
- $0
- Form D file number
- 021-200927
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ROTH CAPITAL PARTNERS, LLC | 15407 | LOUIS J. ELLIS · CRD 4164953 |
Source: Form D, filed Aug 7, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Bertram | Executive |
| Tim Bertram | Executive |
| Carl Johan Dalsgaard | Director |
| A. Brian Davis | Executive |
| A. Brian Davis | Executive |
| Scott D. Flora | Director |
| Brenda D Gavin | Director |
| Diane Jorkasky | Director |
| Richard E. Kuntz | Director |
| Gary J Kurtzman | Director |
| John L. Miclot | Director, Executive |
| Steven Nichtberger | Director, Executive |
| Lorin J. Randall | Director |
| David Scheer | Director |
| Sunita Sheth | Executive |
| Mark Stejbach | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3929 Westpoint Blvd., Suite G
Winston Salem, NC, 27103
Winston Salem, NC, 27103